Photo of Kathryn J. Russo

Kathryn J. Russo is a principal in the Long Island, New York, office of Jackson Lewis P.C. She is a firm resource on the legal issues implicated in workplace drug and alcohol testing arising under federal, state and local laws, as well as substance abuse management and marijuana laws’ impact on employers.

Kathryn helps clients navigate workplace problems involving drugs and alcohol. She regularly works with corporate counsel and human resources executives to develop substance abuse policies to comply with federal drug and alcohol testing regulations (including all agencies of the U.S. Department of Transportation), as well as state and local drug and alcohol testing laws and marijuana laws in all 50 states. In addition, she defends employers in litigation where drug and alcohol test results are at issue, and frequently conducts “reasonable suspicion” training for employers in connection with their substance abuse policies. Kathryn also advises employers on leave and disability management issues arising when employees seek leave or other accommodations related to substance abuse rehabilitation.

The Centers for Disease Control and Prevention (“CDC”) has published a new survey showing that prescription painkiller overdoses have increased sharply among women since 1999. Specifically, the CDC found that deaths from prescription painkiller overdoses among women have increased more than 400% since 1999, compared to 265% among men.  This rise relates to the increased

Washington State’s U.S. Senators, along with five members of the state’s delegation to the House of Representatives, all Democrats, have requested U.S. Attorney General Eric Holder to announce the federal government’s position on Washington State’s and Colorado’s legalization of marijuana as soon as possible.  In a letter to Mr. Holder dated June 17, 2013, the

The Food and Drug Administration announced on April 16, 2013 that it is taking two steps to address the “epidemic levels” of prescription painkiller addiction in the U.S.  First, it announced that it will not approve generic versions of the painkiller OxyContin.  In addition, the FDA approved updated labeling for OxyContin extended-release tablets to describe

The EEOC filed a notice of appeal on April 22, 2013 concerning the dismissal of its suit challenging U.S. Steel’s random alcohol testing program for probationary employees.  A federal district court in the Western District of Pennsylvania ruled on February 20th that U.S. Steel’s random alcohol testing program did not violate the Americans with Disabilities